litlas
ログインアカウント作成

Andrea Gaedigk

1990–2025 年に発表

113
論文数
18,323
被引用数
74
h 指数
107
i10 指数

被引用数

Andrea Gaedigk の年別被引用数1991 年: 被引用 5 件1992 年: 被引用 9 件1993 年: 被引用 10 件1994 年: 被引用 12 件1995 年: 被引用 23 件1996 年: 被引用 19 件1997 年: 被引用 21 件1998 年: 被引用 17 件1999 年: 被引用 44 件2000 年: 被引用 44 件2001 年: 被引用 54 件2002 年: 被引用 39 件2003 年: 被引用 37 件2004 年: 被引用 48 件2005 年: 被引用 43 件2006 年: 被引用 41 件2007 年: 被引用 58 件2008 年: 被引用 65 件2009 年: 被引用 85 件2010 年: 被引用 41 件2011 年: 被引用 67 件2012 年: 被引用 52 件2013 年: 被引用 82 件2014 年: 被引用 80 件2015 年: 被引用 90 件2016 年: 被引用 106 件2017 年: 被引用 102 件2018 年: 被引用 136 件2019 年: 被引用 508 件2020 年: 被引用 624 件2021 年: 被引用 738 件2022 年: 被引用 545 件2023 年: 被引用 398 件2024 年: 被引用 731 件2025 年: 被引用 302 件2026 年: 被引用 10 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,178 件、この内訳の 26.8%イギリス: 引用元論文 340 件、この内訳の 7.7%ドイツ: 引用元論文 260 件、この内訳の 5.9%カナダ: 引用元論文 257 件、この内訳の 5.8%中国: 引用元論文 193 件、この内訳の 4.4%オランダ: 引用元論文 182 件、この内訳の 4.1%スウェーデン: 引用元論文 143 件、この内訳の 3.2%オーストラリア: 引用元論文 139 件、この内訳の 3.2%スペイン: 引用元論文 135 件、この内訳の 3.1%スイス: 引用元論文 128 件、この内訳の 2.9%イタリア: 引用元論文 124 件、この内訳の 2.8%フランス: 引用元論文 86 件、この内訳の 2%
0%26.8%その他 28.1%

機関

分野

  • Pharmacology, Toxicology and Pharmaceutics41.4%
  • Medicine37.3%
  • Biochemistry, Genetics and Molecular Biology14.3%
  • Neuroscience1.6%
  • Computer Science1%
  • Psychology0.9%
  • その他3.5%

トピック

  • Pharmacogenetics and Drug Metabolism18.6%
  • Drug Transport and Resistance Mechanisms5%
  • Pharmaceutical studies and practices3.2%
  • Pharmacological Effects and Toxicity Studies2.4%
  • Treatment of Major Depression2.1%
  • Computational Drug Discovery Methods2%
  • その他66.7%

共著者

全論文

検索で開く
  1. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

    著者: Chad Bousman, James M. Stevenson, Laura B. Ramsey, Katrin Sangkuhl, J. Kevin Hicks, Jeffrey R. Strawn, Ajeet Singh, Gualberto Ruaño, Daniel J. Müller, Evangelia Eirini Tsermpini, Jacob T. Brown, Gillian C. Bell, J. Steven Leeder, Andrea Gaedigk, Stuart A. Scott, Teri E. Klein, Kelly E. Caudle, Jeffrey R. Bishop - Clinical Pharmacology & Therapeutics 2023 被引用: 403

  2. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update

    著者: Craig R. Lee, Jasmine A. Luzum, Katrin Sangkuhl, Roseann S. Gammal, Marc S. Sabatine, Charles Michael Stein, David F. Kisor, Nita A. Limdi, Yee Ming Lee, Stuart A. Scott, Jean‐Sébastien Hulot, Dan M. Roden, Andrea Gaedigk, Kelly E. Caudle, Teri E. Klein, Julie A. Johnson, Alan R. Shuldiner - Clinical Pharmacology & Therapeutics 2022 被引用: 458

  3. The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal Symptoms

    著者: Rhonda M. Cooper‐DeHoff, Mikko Niemi, Laura B. Ramsey, Jasmine A. Luzum, E. Katriina Tarkiainen, Robert J. Straka, Li Gong, Sony Tuteja, Russell A. Wilke, Mia Wadelius, Eric Larson, Dan M. Roden, Teri E. Klein, Sook Wah Yee, Ronald M. Krauss, Richard M. Turner, Latha Palaniappan, Andrea Gaedigk, Kathleen M. Giacomini, Kelly E. Caudle, Deepak Voora - Clinical Pharmacology & Therapeutics 2022 被引用: 331

  4. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

    著者: J K Hicks, JR Bishop, Katrin Sangkuhl, Müller Dj, Yuan Ji, SG Leckband, JS Leeder, RL Graham, DL Chiulli, Adrián LLerena, TC Skaar, Stuart A. Scott, Julia Stingl, Teri E. Klein, KE Caudle, Andrea Gaedigk - Clinical Pharmacology & Therapeutics 2015 被引用: 975

  5. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

    著者: JK Hicks, Katrin Sangkuhl, JJ Swen, VL Ellingrod, Müller Dj, Kazutaka Shimoda, JR Bishop, E D Kharasch, TC Skaar, Andrea Gaedigk, Henry M. Dunnenberger, Teri E. Klein, KE Caudle, Julia Stingl - Clinical Pharmacology & Therapeutics 2016 被引用: 678

  6. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy

    著者: Kristine R. Crews, Andrew A. Monte, Rachel Huddart, Kelly E. Caudle, Evan D. Kharasch, Andrea Gaedigk, Henry M. Dunnenberger, J. Steven Leeder, John T. Callaghan, Caroline Samer, Teri E. Klein, Cyrine E. Haidar, Sara L. Van Driest, Gualberto Ruaño, Katrin Sangkuhl, Larisa H. Cavallari, Daniel J. Müller, Cynthia A. Prows, Mohamed Nagy, Andrew A. Somogyi, Todd C. Skaar - Clinical Pharmacology & Therapeutics 2021 被引用: 399

  7. Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group

    著者: Kelly E. Caudle, Katrin Sangkuhl, Michelle Whirl‐Carrillo, Jesse J. Swen, Cyrine E. Haidar, Teri E. Klein, Roseann S. Gammal, Mary V. Relling, Stuart A. Scott, Daniel L. Hertz, Henk‐Jan Guchelaar, Andrea Gaedigk - Clinical and Translational Science 2019 被引用: 525

  8. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

    著者: John J. Lima, Cameron D. Thomas, Julia M. Barbarino, Zeruesenay Desta, Sara L. Van Driest, Nihal El Rouby, Julie A. Johnson, Larisa H. Cavallari, Valentina Shakhnovich, David Thacker, Stuart A. Scott, Matthias Schwab, Chakradhara Rao S. Uppugunduri, Christine M. Formea, James P. Franciosi, Katrin Sangkuhl, Andrea Gaedigk, Teri E. Klein, Roseann S. Gammal, Takahisa Furuta - Clinical Pharmacology & Therapeutics 2020 被引用: 298

  9. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs

    著者: Katherine N. Theken, Craig R. Lee, Li Gong, Kelly E. Caudle, Christine M. Formea, Andrea Gaedigk, Teri E. Klein, José A. G. Agúndez, Tilo Großer - Clinical Pharmacology & Therapeutics 2020 被引用: 330

  10. Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene Variation

    著者: Andrea Gaedigk, Scott T. Casey, Michelle Whirl‐Carrillo, Neil Miller, Teri E. Klein - Clinical Pharmacology & Therapeutics 2021 被引用: 161

  11. Recommendations for Clinical CYP2D6 Genotyping Allele Selection

    著者: Victoria M. Pratt, Larisa H. Cavallari, Andria L. Del Tredici, Andrea Gaedigk, Houda Hachad, Yuan Ji, Lisa V. Kalman, Reynold C. Ly, Ann M. Moyer, Stuart A. Scott, Ron H. N. van Schaik, Michelle Whirl‐Carrillo, Karen E. Weck - Journal of Molecular Diagnostics 2021 被引用: 154

  12. Prediction of CYP2D6 phenotype from genotype across world populations

    著者: Andrea Gaedigk, Katrin Sangkuhl, Michelle Whirl‐Carrillo, Teri E. Klein, J. Steven Leeder - Genetics in Medicine 2016 被引用: 516

  13. PharmVar GeneFocus: CYP2B6

    著者: Zeruesenay Desta, Ahmed El‐Boraie, Li Gong, Andrew A. Somogyi, Volker M. Lauschke, Collet Dandara, Kathrin Klein, Neil Miller, Teri E. Klein, Rachel F. Tyndale, Michelle Whirl‐Carrillo, Andrea Gaedigk - Clinical Pharmacology & Therapeutics 2021 被引用: 239

  14. PharmVar GeneFocus: CYP2D6

    著者: Charity Nofziger, Amy Turner, Katrin Sangkuhl, Michelle Whirl‐Carrillo, José A. G. Agúndez, John L. Black, Henry M. Dunnenberger, Gualberto Ruaño, Martin A. Kennedy, Michael Phillips, Houda Hachad, Teri E. Klein, Andrea Gaedigk - Clinical Pharmacology & Therapeutics 2019 被引用: 248

  15. The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database

    著者: Andrea Gaedigk, Magnus Ingelman‐Sundberg, Neil Miller, J. Steven Leeder, Michelle Whirl‐Carrillo, Teri E. Klein - Clinical Pharmacology & Therapeutics 2017 被引用: 420

  16. The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype

    著者: Andrea Gaedigk, S.D. Simon, R PEARCE, L. DiAnne Bradford, MJ Kennedy, JS Leeder - Clinical Pharmacology & Therapeutics 2007 被引用: 793

  17. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

    著者: Matthew P. Goetz, Katrin Sangkuhl, Henk‐Jan Guchelaar, Matthias Schwab, Michael A. Province, Michelle Whirl‐Carrillo, W. Fraser Symmans, Howard L. McLeod, Mark J. Ratain, Hitoshi Zembutsu, Andrea Gaedigk, Ron HN van Schaik, James N. Ingle, Kelly E. Caudle, Teri E. Klein - Clinical Pharmacology & Therapeutics 2018 被引用: 324

  18. Review and Consensus on Pharmacogenomic Testing in Psychiatry

    著者: Chad Bousman, Susanne Bengesser, Katherine J. Aitchison, Azmeraw T. Amare, H.N. Aschauer, Bernhard T. Baune, Bahareh Behroozi Asl, Jeffrey R. Bishop, Margit Burmeister, Boris Chaumette, Li-Shiun Chen, Zachary A. Cordner, Jürgen Deckert, Franziska Degenhardt, Lynn E. DeLisi, Lasse Folkersen, James L. Kennedy, Teri E. Klein, Joseph L. McClay, Francis J. McMahon, Richard Musil, Nancy L. Saccone, Katrin Sangkuhl, Robert Stowe, Ene‐Choo Tan, Arun K. Tiwari, Clement C. Zai, Gwyneth Zai, Jianping Zhang, Andrea Gaedigk, Daniel J. Müller - Pharmacopsychiatry 2020 被引用: 211

  19. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline forCYP2D6genotype and use of ondansetron and tropisetron

    著者: GC Bell, KE Caudle, Michelle Whirl‐Carrillo, RJ Gordon, Keiko Hikino, CA Prows, Andrea Gaedigk, JAG Agundez, Senthilkumar Sadhasivam, Teri E. Klein, Matthias Schwab - Clinical Pharmacology & Therapeutics 2016 被引用: 216

  20. PharmVar GeneFocus: CYP2C19

    著者: Mariana Rodrigues Botton, Michelle Whirl‐Carrillo, Andria L. Del Tredici, Katrin Sangkuhl, Larisa H. Cavallari, José A. G. Agúndez, Jorgé Duconge, Ming Ta Michael Lee, Erica L. Woodahl, Karla Claudio‐Campos, Ann K. Daly, Teri E. Klein, Victoria M. Pratt, Stuart A. Scott, Andrea Gaedigk - Clinical Pharmacology & Therapeutics 2020 被引用: 140

  21. Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update

    著者: Kristine R. Crews, Andrea Gaedigk, Henry M. Dunnenberger, J. Steven Leeder, Teri E. Klein, Kelly E. Caudle, Cyrine E. Haidar, Danny D. Shen, John T. Callaghan, Senthilkumar Sadhasivam, Cynthia A. Prows, E D Kharasch, Todd C. Skaar - Clinical Pharmacology & Therapeutics 2014 被引用: 678

  22. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update

    著者: Jason H. Karnes, Allan E. Rettie, Andrew A. Somogyi, Rachel Huddart, Alison E. Fohner, Christine M. Formea, Ming Ta Michael Lee, Adrián LLerena, Michelle Whirl‐Carrillo, Teri E. Klein, Elizabeth J. Phillips, Scott Mintzer, Andrea Gaedigk, Kelly E. Caudle, John T. Callaghan - Clinical Pharmacology & Therapeutics 2020 被引用: 171

  23. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz‐Containing Antiretroviral Therapy

    著者: Zeruesenay Desta, Roseann S. Gammal, Li Gong, Michelle Whirl‐Carrillo, Aditya H. Gaur, Chonlaphat Sukasem, Jennifer Hockings, Alan L. Myers, Marelize Swart, Rachel F. Tyndale, Collen Masimirembwa, Otito F. Iwuchukwu, Sanika Chirwa, Jeffrey L. Lennox, Andrea Gaedigk, Teri E. Klein, David W. Haas - Clinical Pharmacology & Therapeutics 2019 被引用: 179

  24. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy

    著者: Julio D. Duarte, Cameron D. Thomas, Craig R. Lee, Rachel Huddart, José A. G. Agúndez, Jordan Baye, Andrea Gaedigk, Teri E. Klein, David E. Lanfear, Andrew A. Monte, Mohamed Nagy, Matthias Schwab, C. Michael Stein, Chakradhara Rao S. Uppugunduri, Ron H. N. van Schaik, Roseann S. Donnelly, Kelly E. Caudle, Jasmine A. Luzum - Clinical Pharmacology & Therapeutics 2024 被引用: 66